To test this hypothesis, mice bearing a single B78 tumor, on the left flank, were treated with RT administration and IL-12 injection to the skin of the right flank (in the absence of any tumor), together with systemic injections of srIL-2 and anti-CTLA-4. The gene discussed is CTLA4; the disease is neoplasm.